Regency Capital Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-24
Closed -$11K 48
2022
Q2
$11K Sell
24
-12,491
-100% -$6.09M 0.01% 71
2022
Q1
$6.34M Buy
12,515
+2,417
+24% +$1.16M 4.61% 3
2021
Q4
$5.34M Buy
10,098
+1,752
+21% +$841K 3.4% 9
2021
Q3
$3.88M Buy
+8,346
New +$3.93M 2.73% 10

Other funds holding CHE

Regency Capital Management's CHE Position: Q3 2022 in Review

Regency Capital Management sold out of Chemed (CHE) in Q3 2022, closing a stake of 24 shares — an estimated $11K sold.

Regency Capital Management first reported a position in CHE in Q3 2021 and held it in 4 quarters. The position peaked at $6.34M in Q1 2022. 419 funds tracked by Wall St. Rank hold CHE as of Q3 2022.

  • Regency Capital Management reported no remaining Chemed position as of Q3 2022 after selling out during the quarter.
  • Regency Capital Management sold 24 Chemed shares in Q3 2022, an estimated $11K.
  • Regency Capital Management first reported a position in Chemed in Q3 2021 and held it in 4 quarters.
  • Regency Capital Management's Chemed position peaked at $6.34M in Q1 2022.
  • 419 funds tracked by Wall St. Rank held Chemed as of Q3 2022.

Based on Regency Capital Management's 13F filing for Q3 2022, filed 4 Nov 2022.